Skip to main content

Table 1 Hepatic conditions exclusion criteria, identified on the basis of health care claims

From: Hepatic outcomes among adults taking duloxetine: a retrospective cohort study in a US health care claims database

Condition

 

Heart failure

 

Thrombocytopenia

 

Positive markers for hepatitis infections

 

HIV infection

 

Abnormal aminotransferases

 

Abnormal total bilirubin

 

Abnormal transferrin saturation

 

Jaundice/icterus

 

Acute or sub-acute necrosis of liver

 

Veno-occlusive liver disease (not including Budd Chiari syndrome)

 

Liver infarction

 

Hepatic coma

 

Hepatorenal syndrome

 

Chronic liver disease, cirrhosis, and/or fibrosis

 

Chronic hepatitis

 

Chronic active hepatitis

 

Acute hepatitis

 

Alcoholic hepatitis

 

Autoimmune hepatitis

 

Viral hepatitis

 

Unspecified or cryptogenic hepatitis

 

Nonalcoholic hepatitis

 

Biliary tract obstruction, stricture, stones

 

Primary or metastatic neoplasia of the liver and hepatic ducts

 

Primary or metastatic tumors elsewhere

 

Hepatic encephalopathy

 

Liver transplant

 

Ascites

 

Hepatectomy

 

Other liver operations

 

Hereditary hemochromatosis

 

Disorders of copper metabolism (Wilson’s disease)

 

Alpha-1 antitripsin deficiency

 

Celiac disease

 

Sclerosing cholangitis

 

Primary biliary cirrhosis

 

Liver helminth, fluke, parasite

 

Budd-Chiari Syndrome

 

Abdominal trauma